Human antitransforming growth factor β 2 monoclonal antibody—a new modulator of wound healing in trabeculectomy
- 1 March 2002
- journal article
- clinical trial
- Published by Elsevier in Ophthalmology
- Vol. 109 (3) , 427-431
- https://doi.org/10.1016/s0161-6420(01)00997-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A fully human antibody neutralising biologically active human TGFβ2 for use in therapyJournal of Immunological Methods, 1999
- Effectiveness and complications of mitomycin C use during pediatric glaucoma surgeryOphthalmology, 1998
- Aqueous Humor in Glaucomatous Eyes Contains an Increased Level of TGF-β2Experimental Eye Research, 1994
- Long-term Functional Outcome after Early Surgery Compared with Laser and Medicine in Open-angle GlaucomaOphthalmology, 1994
- Activation and suppression of fibroblast functionEye, 1994
- Hypotony Maculopathy Following Trabeculectomy With Mitomycin CArchives of Ophthalmology (1950), 1992
- Rational choice of therapy in primary open angle glaucomaEye, 1992
- Transforming growth factor-β in human aqueous humorCurrent Eye Research, 1990
- Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye.Journal of Clinical Investigation, 1989
- Histologic Characteristics of Filtering Blebs in Glaucomatous EyesArchives of Ophthalmology (1950), 1983